In this case, the combination of refractory EN, abnormal hematologic findings such as circulating blasts, thrombocytosis, and elevated LDH levels served as key indicators prompting further investigation into a potential hematologic malignancy, ultimately leading to the diagnosis of AML-M2 with a FLT3-ITD mutation. This evidence concerns the gene FLT3 and Thrombocytosis.